AVBP ArriVent BioPharma, Inc. Common Stock
Healthcare$27.94+4.53%ClosedMarket Cap: $1.30B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$45.00
Target (Median)
$45.00
Target Range
$45.00 - $45.00
Upside from current price: 61.1%
Rating Distribution
0 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Citigroup | maintain | Buy | Buy |
| 2026-03-23 | B. Riley Securities | maintain | Buy | Buy |
| 2026-03-06 | Citigroup | maintain | Buy | Buy |
| 2026-03-06 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-03-06 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-11 | Citigroup | maintain | Buy | Buy |
| 2025-08-12 | Citigroup | maintain | Buy | Buy |
| 2025-08-12 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-06-24 | Oppenheimer | maintain | Outperform | Outperform |
| 2025-06-24 | Guggenheim | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.33 | $43.7M | 6 |
| Sun Dec 31 | $-1.38 | $141.8M | 6 |
| Mon Dec 31 | $0.75 | $266.8M | 4 |
| Tue Dec 31 | $3.31 | $433.9M | 2 |